Samuel So

Clinical Focus

• Cancer > GI Oncology
• Gastrointestinal Cancers
• Gastrointestinal Cancers - Surgical Oncology
• General Surgery
• Liver Cancer

Administrative Appointments

• Committee on the Prevention and Control of Viral Hepatitis in the United States, Institute of Medicine of the National Academies (2008 - 2010)
• Roundtable on Health Disparity, Institute of Medicine of the National Academies (2008 - 2010)
• Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies (2006 - 2009)
• Conflict of Interest Committee, Stanford University School of Medicine (2008 - 2010)
• Appointments and Promotion Committee, Stanford University School of Medicine (2007 - 2010)
View All 22administrative appointments of Samuel So

Honors and Awards

• Fervent Global Love of Lives Award, Chou-Ta Kuan Cultural and Education Foundation, Taiwan (2008)
• 10th Annual Salute to Excellence Award, American Liver Foundation (2008)
• 34th Annual Award, Chinese Hospital, San Francisco (2007)
• Star Award for Community Service, Asian Americans for Community Involvement, San Jose (2007)
• Best Doctors in America, Woodard/White Compendium (1998-present)

Professional Education

• Fellowship: University of Minnesota School of Medicine, MN (1989)
• Residency: University of Minnesota, MN (1988)
• Internship: University of Minnesota, MN (1981)
• Medical Education: University of Hong Kong, China (1978)
• Fellowship, Univ. of Minnesota, Mpls., MN, Multi-organ Transplantation (1989)

Postdoctoral Advisees

Kin Wai Sun, Zhanhui Wang

Graduate & Fellowship Program Affiliations

• Surgery

Community & International Work

• HBV Catch-up vaccination in China, China 
• Three-for-Life, San Francisco 
• Annual Youth Leadership Conference on API Health, Stanford University 
• Evaluate and Develop Strategies for HBV and Liver Cancer Prevention for the Philippines 

Web Site Links

• Asian Liver Center

Research Interests

Through a 3 pronged comprehensive program: translational and clinical research, early detection and treatment, and promoting education, awareness and immunization, we are working towards the development of new strategies that will lead to the elimination of hepatitis B worldwide and reduce the threat and incidence of liver cancer. Our current research efforts focus on evaluating potential new diagnostic and treatment markers and novel targeted therapy for primary liver cancer.

Publications

• Hepatitis B and liver cancer knowledge and preventive practices among Asian Americans in the San Francisco Bay Area, California. Wu CA, Lin SY, So SK, Chang ET "Asian Pac J Cancer Prev" 2007 Jan-Mar ; 1 (8) : 127-34
• Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B. Hutton DW, Tan D, So SK, Brandeau ML "Ann Intern Med" 2007 ; 7 (147) : 460-9
• Why we should routinely screen Asian American adults for hepatitis B: a cross-sectional study of Asians in California. Lin SY, Chang ET, So SK "Hepatology" 2007 ; 4 (46) : 1034-40
• The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004. Chang ET, Keegan TH, Gomez SL, Le GM, Clarke CA, So SK, Glaser SL "Cancer" 2007 ; 10 (109) : 2100-8
• Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. Chua MS, Sun H, Cheung ST, Mason V, Higgins J, Ross DT, Fan ST, So S "Mod Pathol" 2007 ; 1 (20) : 76-83